ESOP25 May 2026, 09:21 pm
Aarti Pharmalabs Grants 57,600 Stock Options Under PSOP 2023
AI Summary
Aarti Pharmalabs Ltd. announced the grant of 57,600 stock options to eligible employees of the company and its subsidiary under the APL Performance Stock Option Plan 2023 (PSOP 2023). The grant was approved by the Nomination and Remuneration Committee of the Board of Directors on May 25, 2026. The exercise price is set at ₹5 per option, subject to the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Key Highlights
- Aarti Pharmalabs grants 57,600 stock options under PSOP 2023.
- The options are granted to eligible employees of the company and its subsidiary.
- Exercise price is set at ₹5 per option.
- Grant approved by the Nomination and Remuneration Committee on May 25, 2026.
Price Impact
More from AARTIPHARM